Craddock, C., Versluis, J., Labopin, M., Socie, G., Huyn, A., Deconinck, E., . . . Nagler, A. (2016). Characterization of factors determining the kinetics of disease relapse after allogeneic Stem Cell Transplantation (allo-SCT) or chemotherapeutic consolidation for Acute Myeloid Leukaemia (AML) in First CR: A survey from HOVON-SAKK and the acute leukaemia working party of the EBMT. American Society of Hematology.
Chicago-čujuhus (17. p.)Craddock, C., et al. Characterization of Factors Determining the Kinetics of Disease Relapse After Allogeneic Stem Cell Transplantation (allo-SCT) or Chemotherapeutic Consolidation for Acute Myeloid Leukaemia (AML) in First CR: A Survey from HOVON-SAKK and the Acute Leukaemia Working Party of the EBMT. American Society of Hematology, 2016.
MLA-čujuhus (9. p.)Craddock, C., et al. Characterization of Factors Determining the Kinetics of Disease Relapse After Allogeneic Stem Cell Transplantation (allo-SCT) or Chemotherapeutic Consolidation for Acute Myeloid Leukaemia (AML) in First CR: A Survey from HOVON-SAKK and the Acute Leukaemia Working Party of the EBMT. American Society of Hematology, 2016.